| Tradename: | Cysview, Hexvix |
| Dailymedid: | Hexaminolevulinate |
| Atc Prefix: | V04 |
| Atc Suffix: | CX06 |
| Legal Au: | S4 |
| Legal Au Comment: | [1] |
| Legal Ca: | Rx-only |
| Legal Us: | Rx-only |
| Legal Us Comment: | [2] |
| Cas Number: | 140898-97-1 |
| Pubchem: | 6433083 |
| Drugbank: | DB06261 |
| Chemspiderid: | 4938272 |
| Unii: | G7H20TKI67 |
| Kegg: | D04436 |
| Chebi: | 134892 |
| Chembl: | 1201784 |
Hexaminolevulinate, sold under the brand name Cysview among others, is an imaging agent that lights up under blue light during a blue light cystoscopy. It is used to help detect non-muscle invasive bladder cancer (NMIBC), in particular papillary tumors and carcinoma in situ (CIS).
It made by Photocure ASA, a Norwegian pharmaceutical company.
Hexaminolevulinate is a structural analogue to 5-aminolevulinic acid (a precursor to the porphyrin ring of heme), and is internalized and processed into the photoactive protoporphyrin IX at a high rate by tumor cells. After exposure to 360-450 nm light, the porphyrin will fluoresce red.https://pubchem.ncbi.nlm.nih.gov/compound/Hexaminolevulinate#section=Metabolism-Metabolites